Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)

FEBS Letters

Volumn 545, Issue 2-3, 2003, Pages 144-150

  Nieth, Christiane ^a   Priebsch, Axel ^a   Stege, Alexandra ^a   Lage, Hermann ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Gastric cancer; Gene therapy; MDR1; P glycoprotein; Pancreatic cancer

Indexed keywords

DAUNORUBICIN; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; MODULATION; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; WESTERN BLOTTING;

EID: 0037526598     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00523-4     Document Type: Article

References (31)

1. Biedler J.L., Riehm H. Cancer Res. 30:1970;1174-1184.
2. Ling V. Cancer Chemother. Pharmacol. 40:(Suppl):1997;S3-S8.
3. Lage, H. (2003) Int. J. Antimicrob. Agents (in press).
4. Gottesman M.M., Fojo T., Bates S.E. Nat. Rev. Cancer. 2:2002;48-58.
5. Volm M. Anticancer Res. 18:1998;2905-2917.
6. Liu C., Qureshi I.A., Ding X., Shan Y., Huang Y., Xie Y., Ji M. Clin. Sci. 91:1996;93-98.
7. Stuart D.D., Kao G.Y., Allen T.M. Cancer Gene Ther. 7:2000;466-475.
8. Holm P.S., Scanlon K.J., Dietel M. Br. J. Cancer. 70:1994;239-243.
9. Kobayashi H., Dorai T., Holland J.F., Ohnuma T. Cancer Res. 54:1994;1271-1275.
10. Hannon G.J. Nature. 418:2002;244-251.
11. Nykanen A., Haley B., Zamore P.D. Cell. 107:2001;309-321.
12. Ui-Tei K., Zenno S., Miyata Y., Saigo K. FEBS Lett. 479:2000;79-82.
13. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Nature. 411:2001;494-498.
14. Harborth J., Elbashir S.M., Bechert K., Tuschl T., Weber K. J. Cell Sci. 114:2001;4557-4565.
15. Holm P.S., Dietel M., Krupp G. Gene. 167:1995;221-225.
16. Dietel M., Arps H., Lage H., Niendorf A. Cancer Res. 50:1990;6100-6106.
17. Lage H., Dietel M. J. Cancer Res. Clin. Oncol. 128:2002;349-357.
18. Lage H., Jordan A., Scholz R., Dietel M. Int. J. Hyperthermia. 16:2000;291-303.
19. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107-1112.
20. Lage H., Perlitz C., Abele R., Tampé R., Dietel M., Schadendorf D., Sinha P. FEBS Lett. 503:2001;179-184.
21. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., Akiyama S. J. Natl. Cancer Inst. 91:1999;1647-1653.
22. Hatanaka H., Abe Y., Naruke M., Asai S., Miyachi H., Kawakami T., Nagata J., Kamochi J., Kijima H., Yamazaki H., Scanlon K.J., Ueyama Y., Nakamura M. Anticancer Res. 21:2001;879-885.
23. Materna V., Holm P.S., Dietel M., Lage H. Cancer Gene Ther. 8:2001;176-184.
24. Kowalski P., Wichert A., Holm P.S., Dietel M., Lage H. Cancer Gene Ther. 8:2001;185-192.
25. Kowalski P., Stein U., Scheffer G.L., Lage H. Cancer Gene Ther. 9:2002;579-586.
26. Brummelkamp T.R., Bernards R., Agami R. Science. 296:2002;550-553.
27. Scherr M., Battmer K., Winkler T., Heidenreich O., Ganser A., Eder M. Blood. 101:2003;1566-1569.
28. Martinez L.A., Naguibneva I., Lehrmann H., Vervisch A., Tchenio T., Lozano G., Harel-Bellan A. Proc. Natl. Acad. Sci. USA. 99:2002;14849-14854.
29. Wu H., Hait W.N., Yang J.-M. Cancer Res. 63:2003;1515-1519.
30. Beaulieu E., Demeule M., Ghitescu L., Beliveau R. Biochem J. 326:1997;539-544.
31. Holm, P.S., Lage, H., Bergmann, S., Jürchott, K., Glockzin, G., Bernshausen, A., Mantwill, K., Ladhoff, A., Wichert, A., Mymryk, J.S., Ritter, T., Dietel, M., Gänsbacher, B. and Royer, H.-D. (2003) Cancer Res. (in press).